Marino Michael F III — SEC Form 4 filings
SEC reporting owner CIK 1502700. 12 Form 4 filings on record with FilingPulse; latest filed 2025-06-03.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-29 to 2025-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 79,347 shares, $108,905 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 49,408 shares @ $1.14 ($56,325) in OptiNose, Inc., filed 2024-07-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OptiNose, Inc. (OPTN) | Chief Legal Officer & Corp Sec | 11 | — | 8 legs · 79,347 sh · $108,905 | 16 |
| NewAmsterdam Pharma Co N.V. (NAMS) | See Remarks | 1 | — | — | 2 |
Form 4 filings — Marino Michael F III
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-03 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 55,000 · Grant/award (A): 315,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | OptiNose, Inc. (OPTN) | Disposition to issuer (D): 125,204 · Disposition to issuer (D): 10,575 (derivative) · Disposition to issuer (D): 9,333 (derivative) · Disposition to issuer (D): 16,752 (derivative) · Disposition to issuer (D): 12,350 (derivative) · Disposition to issuer (D): 5,333 (derivative) · +4 more | EDGAR |
| 2025-03-19 | 4 | OptiNose, Inc. (OPTN) | Sale (S): 246 @ $5.61 | EDGAR |
| 2025-03-04 | 4 | OptiNose, Inc. (OPTN) | Sale (S): 2,145 @ $5.29 | EDGAR |
| 2025-02-26 | 4 | OptiNose, Inc. (OPTN) | Grant/award (A): 21,150 @ $0 · Grant/award (A): 10,575 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | OptiNose, Inc. (OPTN) | Sale (S): 3,050 @ $0.44 | EDGAR |
| 2024-09-18 | 4 | OptiNose, Inc. (OPTN) | Sale (S): 3,226 @ $0.87 | EDGAR |
| 2024-07-18 | 4 | OptiNose, Inc. (OPTN) | Sale (S): 49,408 @ $1.14 | EDGAR |
| 2024-06-20 | 4 | OptiNose, Inc. (OPTN) | Sale (S): 2,946 @ $1.19 | EDGAR |
| 2024-06-18 | 4 | OptiNose, Inc. (OPTN) | Grant/award (A): 3,817 @ $0 · Sale (S): 3,267 @ $1.19 | EDGAR |
| 2024-03-19 | 4 | OptiNose, Inc. (OPTN) | Grant/award (A): 3,816 @ $0 · Sale (S): 15,059 @ $1.88 | EDGAR |
| 2024-02-29 | 4 | OptiNose, Inc. (OPTN) | Grant/award (A): 280,000 @ $0 · Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1502700 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →